)
Hans Melo
CEO
Menten AI, Inc.
Dr. Hans Melo is the co-founder and CEO of Menten AI, a biotechnology company developing generative AI to design next-generation cyclic peptide therapeutics for challenging drug targets beyond the reach of small molecules and biologics. Hans holds a Ph.D. in computational neuroscience from the University of Toronto, where his research focused on reinforcement learning. He brings a multidisciplinary background spanning machine learning, computer science, and quantum computing to drug discovery, and is a frequent speaker at international biotech and drug discovery forums.
)
)
){kind=logo}
){kind=logo}
)
)
){kind=logo}
){kind=logo}